Author:
Köpf-Maier Petra,Leitner Manfred,Voigtländer Rolf,Köpf Hartmut
Abstract
The antitumor activity of molybdocene dichloride is tested against Ehrlich ascites tumor in CF1 mice. The application of 75 or 100 mg/kg 24 h after transplantation achieves 100% tumor inhibition until day 30.
Following the d0 and d1 metallocene dichlorides of titanium and vanadium, molybdocene dichloride is the First analogous d2 system revealing similar antineoplastic properties.
Subject
General Biochemistry, Genetics and Molecular Biology
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献